David A. Siegel Sensus Healthcare, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 85,600 shares of SRTS stock, worth $720,752. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,600
Previous 166,100
48.46%
Holding current value
$720,752
Previous $885,000
43.95%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SRTS
# of Institutions
55Shares Held
3.88MCall Options Held
24.9KPut Options Held
800-
Vanguard Group Inc Valley Forge, PA779KShares$6.56 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny409KShares$3.45 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA304KShares$2.56 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX290KShares$2.44 Million0.0% of portfolio
-
Morgan Stanley New York, NY185KShares$1.56 Million0.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $139M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...